The NFIL3 transcription factor is preferentially expressed in BCR-independent mature B-cell malignancy

Registros relacionados

• Vitamin D receptor expression in plasmablastic lymphoma and myeloma cells confers susceptibility to vitamin D
  por: Gascoyne, D, et al.
  Publicado em: (2016)
• FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas
  por: Brown, P, et al.
  Publicado em: (2015)
• The transcription factor NFIL3 controls regulatory T-cell function and stability
  por: Hyeong Su Kim, et al.
  Publicado em: (2019-07-01)
• FOXP2-positive diffuse large B-cell lymphomas exhibit a poor response to R-CHOP therapy and distinct biological signatures
  por: Wong, K, et al.
  Publicado em: (2016)
• Diurnal Rhythmicity Programs of Microbiota and Transcriptional Oscillation of Circadian Regulator, NFIL3
  por: Masato Kubo, et al.
  Publicado em: (2020-09-01)